Literature DB >> 17002273

Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization.

Yuan Luo1, Kyouhei Arita, Monica Bhatia, Bryan Knuckley, Young-Ho Lee, Michael R Stallcup, Mamoru Sato, Paul R Thompson.   

Abstract

Protein arginine deiminase 4 (PAD4) is a transcriptional coregulator that catalyzes the calcium-dependent conversion of specific arginine residues in proteins to citrulline. Recently, we reported the synthesis and characterization of F-amidine, a potent and bioavailable irreversible inactivator of PAD4. Herein, we report our efforts to identify the steric and leaving group requirements for F-amidine-induced PAD4 inactivation, the structure of the PAD4-F-amidine x calcium complex, and in vivo studies with N-alpha-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide (Cl-amidine), a PAD4 inactivator with enhanced potency. The PAD4 inactivators described herein will be useful pharmacological probes in characterizing the incompletely defined physiological role(s) of this enzyme. In addition, they represent potential lead compounds for the treatment of rheumatoid arthritis because a growing body of evidence supports a role for PAD4 in the onset and progression of this chronic autoimmune disorder.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17002273      PMCID: PMC1808342          DOI: 10.1021/bi061180d

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  33 in total

1.  Deimination of arginine residues in nucleophosmin/B23 and histones in HL-60 granulocytes.

Authors:  Teruki Hagiwara; Katsuhiko Nakashima; Hisashi Hirano; Tatsuo Senshu; Michiyuki Yamada
Journal:  Biochem Biophys Res Commun       Date:  2002-01-25       Impact factor: 3.575

2.  Overexpression of peptidylarginine deiminase IV features in apoptosis of haematopoietic cells.

Authors:  G-Y Liu; Y-F Liao; W-H Chang; C-C Liu; M-C Hsieh; P-C Hsu; G J Tsay; H-C Hung
Journal:  Apoptosis       Date:  2006-02       Impact factor: 4.677

3.  A fluoroacetamidine-based inactivator of protein arginine deiminase 4: design, synthesis, and in vitro and in vivo evaluation.

Authors:  Yuan Luo; Bryan Knuckley; Young-Ho Lee; Michael R Stallcup; Paul R Thompson
Journal:  J Am Chem Soc       Date:  2006-02-01       Impact factor: 15.419

4.  The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.

Authors:  G A Schellekens; H Visser; B A de Jong; F H van den Hoogen; J M Hazes; F C Breedveld; W J van Venrooij
Journal:  Arthritis Rheum       Date:  2000-01

5.  Regulation of coactivator complex assembly and function by protein arginine methylation and demethylimination.

Authors:  Young-Ho Lee; Scott A Coonrod; W Lee Kraus; Mary Anne Jelinek; Michael R Stallcup
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-24       Impact factor: 11.205

6.  In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum.

Authors:  C Masson-Bessière; M Sebbag; J J Durieux; L Nogueira; C Vincent; E Girbal-Neuhauser; R Durroux; A Cantagrel; G Serre
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

7.  Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.

Authors:  G A Schellekens; B A de Jong; F H van den Hoogen; L B van de Putte; W J van Venrooij
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

8.  Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule.

Authors:  Jonathan A Hill; Scott Southwood; Alessandro Sette; Anthony M Jevnikar; David A Bell; Ewa Cairns
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

9.  Human PAD4 regulates histone arginine methylation levels via demethylimination.

Authors:  Yanming Wang; Joanna Wysocka; Joyce Sayegh; Young-Ho Lee; Julie R Perlin; Lauriebeth Leonelli; Lakshmi S Sonbuchner; Charles H McDonald; Richard G Cook; Yali Dou; Robert G Roeder; Steven Clarke; Michael R Stallcup; C David Allis; Scott A Coonrod
Journal:  Science       Date:  2004-09-02       Impact factor: 47.728

10.  Crystallization and preliminary X-ray crystallographic analysis of human peptidylarginine deiminase V.

Authors:  Kyouhei Arita; Hiroshi Hashimoto; Toshiyuki Shimizu; Michiyuki Yamada; Mamoru Sato
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2003-11-27
View more
  127 in total

1.  Citrullination of proteins: a common post-translational modification pathway induced by different nanoparticles in vitro and in vivo.

Authors:  Bashir M Mohamed; Navin K Verma; Anthony M Davies; Aoife McGowan; Kieran Crosbie-Staunton; Adriele Prina-Mello; Dermot Kelleher; Catherine H Botting; Corey P Causey; Paul R Thompson; Ger Jm Pruijn; Elena R Kisin; Alexey V Tkach; Anna A Shvedova; Yuri Volkov
Journal:  Nanomedicine (Lond)       Date:  2012-05-25       Impact factor: 5.307

2.  Activity-based protein profiling of protein arginine methyltransferase 1.

Authors:  Obiamaka Obianyo; Corey P Causey; Justin E Jones; Paul R Thompson
Journal:  ACS Chem Biol       Date:  2011-08-23       Impact factor: 5.100

3.  Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors.

Authors:  Justin E Jones; Jessica L Slack; Pengfei Fang; Xuesen Zhang; Venkataraman Subramanian; Corey P Causey; Scott A Coonrod; Min Guo; Paul R Thompson
Journal:  ACS Chem Biol       Date:  2011-10-21       Impact factor: 5.100

4.  Photochemical Control of Protein Arginine Deiminase (PAD) Activity.

Authors:  Santanu Mondal; Sangram S Parelkar; Mitesh Nagar; Paul R Thompson
Journal:  ACS Chem Biol       Date:  2018-03-16       Impact factor: 5.100

Review 5.  Minireview: protein arginine methylation of nonhistone proteins in transcriptional regulation.

Authors:  Young-Ho Lee; Michael R Stallcup
Journal:  Mol Endocrinol       Date:  2009-01-22

6.  Lupus and proliferative nephritis are PAD4 independent in murine models.

Authors:  Rachael A Gordon; Jan M Herter; Florencia Rosetti; Allison M Campbell; Hiroshi Nishi; Michael Kashgarian; Sheldon I Bastacky; Anthony Marinov; Kevin M Nickerson; Tanya N Mayadas; Mark J Shlomchik
Journal:  JCI Insight       Date:  2017-05-18

7.  Seeing citrulline: development of a phenylglyoxal-based probe to visualize protein citrullination.

Authors:  Kevin L Bicker; Venkataraman Subramanian; Alexander A Chumanevich; Lorne J Hofseth; Paul R Thompson
Journal:  J Am Chem Soc       Date:  2012-10-03       Impact factor: 15.419

8.  Haloacetamidine-based inactivators of protein arginine deiminase 4 (PAD4): evidence that general acid catalysis promotes efficient inactivation.

Authors:  Bryan Knuckley; Corey P Causey; Perry J Pellechia; Paul F Cook; Paul R Thompson
Journal:  Chembiochem       Date:  2010-01-25       Impact factor: 3.164

9.  D-amino acid based protein arginine deiminase inhibitors: Synthesis, pharmacokinetics, and in cellulo efficacy.

Authors:  Kevin L Bicker; Lynne Anguish; Alexander A Chumanevich; Michael D Cameron; Xiangli Cui; Erin Witalison; Venkataraman Subramanian; Xuesen Zhang; Alena P Chumanevich; Lorne J Hofseth; Scott A Coonrod; Paul R Thompson
Journal:  ACS Med Chem Lett       Date:  2012-10-26       Impact factor: 4.345

10.  Cl-Amidine Prevents Histone 3 Citrullination and Neutrophil Extracellular Trap Formation, and Improves Survival in a Murine Sepsis Model.

Authors:  Bethany M Biron; Chun-Shiang Chung; Xian M O'Brien; Yaping Chen; Jonathan S Reichner; Alfred Ayala
Journal:  J Innate Immun       Date:  2016-09-14       Impact factor: 7.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.